Healthpeak Properties, Inc. (NYSE:PEAK) Receives Average Recommendation of “Hold” from Analysts
Shares of Healthpeak Properties, Inc. (NYSE:PEAK – Get Free Report) have been assigned an average recommendation of “Hold” from the eleven brokerages that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $23.88.
A number of analysts recently weighed in on the stock. BNP Paribas assumed coverage on shares of Healthpeak Properties in a report on Wednesday, October 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. Wedbush reaffirmed a “neutral” rating and issued a $19.00 price objective on shares of Healthpeak Properties in a report on Tuesday, October 31st. Bank of America cut shares of Healthpeak Properties from a “neutral” rating to an “underperform” rating and set a $17.50 price objective on the stock. in a report on Monday, November 13th. Morgan Stanley dropped their price objective on shares of Healthpeak Properties from $25.00 to $22.00 and set an “equal weight” rating on the stock in a report on Thursday, September 7th. Finally, Scotiabank dropped their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set a “sector perform” rating on the stock in a report on Thursday, October 5th.
Get Our Latest Research Report on PEAK
Healthpeak Properties Trading Up 5.1 %
NYSE PEAK opened at $18.20 on Friday. Healthpeak Properties has a 12 month low of $15.24 and a 12 month high of $28.43. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.58 and a quick ratio of 0.58. The company has a market capitalization of $9.96 billion, a price-to-earnings ratio of 41.36, a price-to-earnings-growth ratio of 7.90 and a beta of 1.00. The company’s fifty day moving average price is $17.00 and its two-hundred day moving average price is $19.30.
Healthpeak Properties (NYSE:PEAK – Get Free Report) last posted its quarterly earnings results on Monday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.38% and a net margin of 11.17%. The business had revenue of $556.20 million during the quarter, compared to the consensus estimate of $543.57 million. During the same quarter in the previous year, the business posted $0.43 earnings per share. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. As a group, research analysts predict that Healthpeak Properties will post 1.77 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, November 20th. Shareholders of record on Tuesday, November 7th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.59%. The ex-dividend date of this dividend was Monday, November 6th. Healthpeak Properties’s payout ratio is 272.73%.
Institutional Trading of Healthpeak Properties
Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Healthpeak Properties by 1.7% during the first quarter. Vanguard Group Inc. now owns 87,540,866 shares of the company’s stock worth $3,005,279,000 after purchasing an additional 1,479,620 shares during the period. State Street Corp raised its position in Healthpeak Properties by 0.7% during the second quarter. State Street Corp now owns 39,522,044 shares of the company’s stock valued at $794,393,000 after acquiring an additional 290,998 shares in the last quarter. Invesco Ltd. raised its position in Healthpeak Properties by 5.3% during the third quarter. Invesco Ltd. now owns 24,135,247 shares of the company’s stock valued at $443,123,000 after acquiring an additional 1,216,192 shares in the last quarter. JPMorgan Chase & Co. raised its position in Healthpeak Properties by 5.5% during the third quarter. JPMorgan Chase & Co. now owns 16,476,078 shares of the company’s stock valued at $302,501,000 after acquiring an additional 865,746 shares in the last quarter. Finally, Norges Bank bought a new position in Healthpeak Properties during the fourth quarter valued at approximately $386,590,000. 92.55% of the stock is currently owned by institutional investors and hedge funds.
About Healthpeak Properties (Get Free Report
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Healthpeak Properties, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Healthpeak Properties wasn’t on the list.
While Healthpeak Properties currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.